FI905788A0 - Menetelmä terapeuttisesti käyttökelpoisten 6-aryyli-5,6-dihydroimidatso/2,1-b/tiatsolijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 6-aryyli-5,6-dihydroimidatso/2,1-b/tiatsolijohdannaisten valmistamiseksi

Info

Publication number
FI905788A0
FI905788A0 FI905788A FI905788A FI905788A0 FI 905788 A0 FI905788 A0 FI 905788A0 FI 905788 A FI905788 A FI 905788A FI 905788 A FI905788 A FI 905788A FI 905788 A0 FI905788 A0 FI 905788A0
Authority
FI
Finland
Prior art keywords
6alkyl
aryl
dihydroimidazo
compounds
thiazole derivatives
Prior art date
Application number
FI905788A
Other languages
English (en)
Swedish (sv)
Other versions
FI905788A (fi
FI93459C (fi
FI93459B (fi
Inventor
Alfons Herman Marg Raeymaekers
Leopold Frans Corneel Roevens
Laerhoven Willy Joannes Ca Van
Wauwe Jean Pierre Frans Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI905788A0 publication Critical patent/FI905788A0/fi
Publication of FI905788A publication Critical patent/FI905788A/fi
Priority to FI933205A priority Critical patent/FI95248C/fi
Application granted granted Critical
Publication of FI93459B publication Critical patent/FI93459B/fi
Publication of FI93459C publication Critical patent/FI93459C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI905788A 1989-11-24 1990-11-23 Menetelmä terapeuttisesti käyttökelpoisten 6-aryyli-5,6-dihydroimidatso/2,1-b/tiatsolijohdannaisten valmistamiseksi FI93459C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI933205A FI95248C (fi) 1989-11-24 1993-07-14 Tiatsolietanolijohdannaisia, menetelmä niiden valmistamiseksi ja niiden välituotteet

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44084289A 1989-11-24 1989-11-24
US44084289 1989-11-24

Publications (4)

Publication Number Publication Date
FI905788A0 true FI905788A0 (fi) 1990-11-23
FI905788A FI905788A (fi) 1991-05-25
FI93459B FI93459B (fi) 1994-12-30
FI93459C FI93459C (fi) 1995-04-10

Family

ID=23750399

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905788A FI93459C (fi) 1989-11-24 1990-11-23 Menetelmä terapeuttisesti käyttökelpoisten 6-aryyli-5,6-dihydroimidatso/2,1-b/tiatsolijohdannaisten valmistamiseksi

Country Status (25)

Country Link
EP (1) EP0430334B1 (fi)
JP (1) JPH03170487A (fi)
KR (1) KR910009714A (fi)
CN (1) CN1032754C (fi)
AT (1) ATE127795T1 (fi)
AU (1) AU630766B2 (fi)
BG (1) BG60587B1 (fi)
CA (1) CA2028756A1 (fi)
CZ (1) CZ281422B6 (fi)
DE (1) DE69022370T2 (fi)
FI (1) FI93459C (fi)
HU (1) HU206361B (fi)
IE (1) IE67656B1 (fi)
IL (1) IL96435A (fi)
MY (1) MY131024A (fi)
NO (1) NO300065B1 (fi)
NZ (1) NZ236026A (fi)
PL (1) PL165413B1 (fi)
PT (1) PT95978B (fi)
RO (1) RO108869B1 (fi)
RU (1) RU2051153C1 (fi)
YU (1) YU47955B (fi)
ZA (1) ZA909445B (fi)
ZM (1) ZM5390A1 (fi)
ZW (1) ZW17890A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0524055A1 (fr) * 1991-07-19 1993-01-20 Synthelabo Dérivés d'imidazo[2,1-b]benzothiazole-3-acétamide, leur préparation et leur application en thérapeutique
US6165253A (en) * 1994-05-23 2000-12-26 New Jersey Institute Of Technology Apparatus for removal of volatile organic compounds from gaseous mixtures
EP1797880A3 (en) * 1999-01-29 2010-04-28 Board Of Trustees Of The University Of Illinois P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
DE60037394T2 (de) 1999-01-29 2009-01-02 The Board Of Trustees For The University Of Illinois, Urbana VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
ES2594083T3 (es) 2004-09-28 2016-12-15 Quark Pharmaceuticals, Inc. Oligorribonucleótidos y métodos de uso de los mismos para tratamiento de la alopecia, insuficiencia renal aguda y otras enfermedades
US7825099B2 (en) 2006-01-20 2010-11-02 Quark Pharmaceuticals, Inc. Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
US7910566B2 (en) 2006-03-09 2011-03-22 Quark Pharmaceuticals Inc. Prevention and treatment of acute renal failure and other kidney diseases by inhibition of p53 by siRNA
DK2170403T3 (da) 2007-06-27 2014-06-16 Quark Pharmaceuticals Inc Sammensætninger og fremgangsmåder til hæmning af ekspressionen af proapoptotiske gener
CN104557979A (zh) * 2013-10-23 2015-04-29 丹阳恒安化学科技研究所有限公司 盐酸左旋咪唑的制备方法
RU2763739C1 (ru) * 2021-06-28 2021-12-30 Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" (ПГНИУ) (Z)-9-ароил-8-гидрокси-6-(2-гидроксифенил)-2-(((Z)-2-оксоиндолин-3-илиден)гидразоно)-1-тиа-3,6-диазаспиро[4.4]нон-8-ен-4,7-дионы, обладающие противомикробной активностью
WO2023093700A1 (zh) * 2021-11-29 2023-06-01 中国海洋大学 咪唑并噻唑衍生物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU409983B2 (en) * 1965-07-19 1970-12-31 Imperial Chemical Industries Of Australia New Zealand Limited Process for the manufacture of thia zolidines and thiazolidines produced thereby
GB1444743A (en) * 1973-09-20 1976-08-04 Pfizer Ltd 7-substituted imidazo-1,1-b-thiazolium and 9-substituted thiazolo-3,2-a-benzimidazolium derivatives having hypogly caemic and/or growth promotant properties
US4340738A (en) * 1979-06-21 1982-07-20 Janssen Pharmaceutica, N.V. 2,3-Dihydro-imidazo[2,1-b]benzothiazoles

Also Published As

Publication number Publication date
DE69022370T2 (de) 1996-03-14
ZA909445B (en) 1992-07-29
IL96435A (en) 1995-03-15
FI905788A (fi) 1991-05-25
DE69022370D1 (de) 1995-10-19
YU47955B (sh) 1996-07-24
YU220890A (sh) 1992-12-21
RO108869B1 (ro) 1994-09-30
KR910009714A (ko) 1991-06-28
NO300065B1 (no) 1997-04-01
ZM5390A1 (en) 1992-06-30
NO905086L (no) 1991-05-27
NO905086D0 (no) 1990-11-23
IE67656B1 (en) 1996-04-17
BG93298A (bg) 1993-12-24
BG60587B1 (bg) 1995-09-29
PL165413B1 (pl) 1994-12-30
CN1032754C (zh) 1996-09-11
MY131024A (en) 2007-07-31
FI93459C (fi) 1995-04-10
PT95978A (pt) 1991-09-13
AU6680990A (en) 1991-05-30
IL96435A0 (en) 1991-08-16
HUT59414A (en) 1992-05-28
IE904241A1 (en) 1991-06-05
JPH03170487A (ja) 1991-07-24
EP0430334A1 (en) 1991-06-05
RU2051153C1 (ru) 1995-12-27
PL287907A1 (en) 1992-04-21
HU206361B (en) 1992-10-28
EP0430334B1 (en) 1995-09-13
CA2028756A1 (en) 1991-05-25
ZW17890A1 (en) 1992-07-08
CZ281422B6 (cs) 1996-09-11
CZ580390A3 (en) 1996-06-12
PT95978B (pt) 1998-01-30
FI93459B (fi) 1994-12-30
NZ236026A (en) 1992-03-26
HU907633D0 (en) 1991-06-28
AU630766B2 (en) 1992-11-05
ATE127795T1 (de) 1995-09-15
CN1052117A (zh) 1991-06-12

Similar Documents

Publication Publication Date Title
PT89047A (pt) Processo para a preparacao de derivados de piridazinamina
EP0352960A3 (en) Purine compounds, process for their preparation and pharmaceutical compositions
HU901627D0 (en) Process for the preparation of novel n-(3-hydroxy-4-piperidinyl)-dihydrobenzofurane-,-dihydro-2h-benzopyrane- and -dihydro-benzo-dioxy-carboxamide derivatives and pharmaceutical compositions containing them
FI905788A (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-aryyli-5,6-dihydroimidatso/2,1-b/tiatsolijohdannaisten valmistamiseksi
FI893701A0 (fi) Menetelmä antipsykoottisten 3-piperatsinyylibentsatsolijohdannaisten valmistamiseksi
PT90034A (pt) Processo para a preparacao de tetra-hidroimidazo-{1,4}benzodiazepina-2-onas
DK361587D0 (da) Thiazolyleddikesyrederivater og fremgangsmaader til fremstilling deraf
PH25531A (en) Novel substituted n-(3-hydroxy-4-piperidinyl)-benzamides, pharmaceutical composition containing said compound, method of use thereof
NO179553C (no) Analogifremgangsmåte for fremstilling av antirhinovirale alkylfenoletre
AU5494290A (en) Antirhinoviral pyridazinamines
PT91613A (pt) Process for the preparation of antihypertensive 3-piperidinyl-indazole derivatives

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: JANSSEN PHARMACEUTICA N.V.